Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation

Circulation. 2022 Nov 29;146(22):1730-1732. doi: 10.1161/CIRCULATIONAHA.122.060596. Epub 2022 Nov 28.

Authors

Pooja Prasad¹, Stacey Howell², Saket Sanghai¹, Eric Stecker¹, Charles A Henrikson¹, Ahmad Masri¹, Babak Nazer¹

Affiliations

¹ Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (P.P., S.S., E.S., C.A.H., A.M., B.N.).
² University of California, San Francisco Cardiac Electrophysiology and Arrhythmia Service (S.H.).

PMID: 36441818
DOI: 10.1161/CIRCULATIONAHA.122.060596

No abstract available

Keywords: amyloidosis; atrial fibrillation; atrial flutter; hypertrophy, left ventricular.

Publication types

Letter

MeSH terms

Amyloidosis* / diagnosis
Atrial Fibrillation* / diagnosis
Cardiomyopathies* / diagnosis
Cardiomyopathies* / genetics
Humans
Mass Screening
Prealbumin / genetics

Substances

Prealbumin